Agonist-Selective Mechanisms of μ-Opioid Receptor Desensitization in Human Embryonic Kidney 293 Cells

The ability of two opioid agonists, [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) and morphine, to induce μ-opioid receptor (MOR) phosphorylation, desensitization, and internalization was examined in human embryonic kidney (HEK) 293 cells expressing rat MOR1 as well G protein-coupled inwardly rectifying potassium channel (GIRK) channel subunits. Both DAMGO and morphine activated GIRK currents, but the maximum response to DAMGO was greater than that of morphine, indicating that morphine is a partial agonist. The responses to DAMGO and morphine desensitized rapidly in the presence of either drug. Expression of a dominant negative mutant G protein-coupled receptor kinase 2 (GRK2), GRK2-K220R, markedly attenuated the DAMGO-induced desensitization of MOR1, but it had no effect on morphine-induced MOR1 desensitization. In contrast, inhibition of protein kinase C (PKC) either by the PKC inhibitory peptide PKC (19-31) or staurosporine reduced MOR1 desensitization by morphine but not that induced by DAMGO. Morphine and DAMGO enhanced MOR1 phosphorylation over basal. The PKC inhibitor bisindolylmaleimide 1 (GF109203X) inhibited MOR1 phosphorylation under basal conditions and in the presence of morphine, but it did not inhibit DAMGO-induced phosphorylation. DAMGO induced arrestin-2 translocation to the plasma membrane and considerable MOR1 internalization, whereas morphine did not induce arrestin-2 translocation and induced very little MOR1 internalization. Thus, DAMGO and morphine each induce desensitization of MOR1 signaling in HEK293 cells but by different molecular mechanisms; DAMGO-induced desensitization is GRK2-dependent, whereas morphine-induced desensitization is in part PKC-dependent. MORs desensitized by DAMGO activation are then readily internalized by an arrestin-dependent mechanism, whereas those desensitized by morphine are not. These data suggest that opioid agonists induce different conformations of the MOR that are susceptible to different desensitizing and internalization processes.

[1]  John T. Williams,et al.  Morphine-Induced μ-Opioid Receptor Desensitization , 2005, Molecular Pharmacology.

[2]  Sadashiva S Karnik,et al.  Multiple Signaling States of G-Protein-Coupled Receptors , 2005, Pharmacological Reviews.

[3]  A. Burlingame,et al.  Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. , 2005, Biochemistry.

[4]  M. Connor,et al.  Opioids: cellular mechanisms of tolerance and physical dependence. , 2005, Current opinion in pharmacology.

[5]  J. Benovic,et al.  Bimodal Regulation of the Human H1 Histamine Receptor by G Protein-coupled Receptor Kinase 2* , 2005, Journal of Biological Chemistry.

[6]  S. Schulz,et al.  Receptor Endocytosis Counteracts the Development of Opioid Tolerance , 2005, Molecular Pharmacology.

[7]  E. Kelly,et al.  Protein Kinase C Activation Enhances Morphine-Induced Rapid Desensitization of μ-Opioid Receptors in Mature Rat Locus Ceruleus Neurons , 2004, Molecular Pharmacology.

[8]  M. Connor,et al.  μ‐Opioid receptor desensitization: Is morphine different? , 2004 .

[9]  S. Schulz,et al.  Morphine induces terminal μ‐opioid receptor desensitization by sustained phosphorylation of serine‐375 , 2004, The EMBO journal.

[10]  M. Caron,et al.  Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. , 2004, Molecular pharmacology.

[11]  C. Chavkin,et al.  Distinct domains of the mu-opioid receptor control uncoupling and internalization. , 2004, Molecular pharmacology.

[12]  S. Schulz,et al.  Phospholipase D2 modulates agonist‐induced µ‐opioid receptor desensitization and resensitization , 2003, Journal of neurochemistry.

[13]  J. Traynor,et al.  The [35S]GTPγS binding assay: approaches and applications in pharmacology , 2003 .

[14]  E. Kelly,et al.  μ-Opioid Receptor Desensitization in Mature Rat Neurons: Lack of Interaction between DAMGO and Morphine , 2003, The Journal of Neuroscience.

[15]  Terry Kenakin,et al.  Ligand-selective receptor conformations revisited: the promise and the problem. , 2003, Trends in pharmacological sciences.

[16]  J. Furness,et al.  Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid Receptors* , 2003, Journal of Biological Chemistry.

[17]  S. Schulz,et al.  ADP-ribosylation Factor-dependent Phospholipase D2 Activation Is Required for Agonist-induced μ-Opioid Receptor Endocytosis* , 2003, The Journal of Biological Chemistry.

[18]  E. Kelly,et al.  G protein‐coupled receptor kinase 6 (GRK6) selectively regulates endogenous secretin receptor responsiveness in NG108‐15 cells , 2003, British journal of pharmacology.

[19]  R. Schulz,et al.  Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3. , 2002, The Journal of pharmacology and experimental therapeutics.

[20]  J. Whistler,et al.  Endocytosis of the Mu Opioid Receptor Reduces Tolerance and a Cellular Hallmark of Opiate Withdrawal , 2001, Neuron.

[21]  C. Krieger,et al.  Modulation of NMDA‐mediated excitotoxicity by protein kinase C , 2001, Journal of neurochemistry.

[22]  L. Dekker,et al.  Regulation of a G protein‐gated inwardly rectifying K+ channel by a Ca2+‐independent protein kinase C , 2001, The Journal of physiology.

[23]  Allen H. Li,et al.  G protein‐coupled receptor kinase 2 mediates µ‐opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus , 2001, Journal of neurochemistry.

[24]  V. Gurevich,et al.  Threonine 180 Is Required for G-protein-coupled Receptor Kinase 3- and β-Arrestin 2-mediated Desensitization of the μ-Opioid Receptor in Xenopus Oocytes* , 2001, The Journal of Biological Chemistry.

[25]  S. Mundell,et al.  Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking. , 2000, Biochemistry.

[26]  A. Duttaroy,et al.  In vivo regulation of μ‐opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice , 2000 .

[27]  G. King,et al.  Identification of PKC-isoform-specific biological actions using pharmacological approaches. , 2000, Trends in pharmacological sciences.

[28]  H. Ueda,et al.  Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice. , 2000, The Journal of pharmacology and experimental therapeutics.

[29]  Hung-Li Wang,et al.  A cluster of Ser/Thr residues at the C-terminus of μ-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization , 2000, Neuropharmacology.

[30]  H. Loh,et al.  The Absence of a Direct Correlation between the Loss of [d-Ala2,MePhe4,Gly5-ol]Enkephalin Inhibition of Adenylyl Cyclase Activity and Agonist-induced μ-Opioid Receptor Phosphorylation* , 1999, The Journal of Biological Chemistry.

[31]  E. J. Simon,et al.  Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists. , 1999, Journal of neurochemistry.

[32]  J. Whistler,et al.  Morphine-activated opioid receptors elude desensitization by β-arrestin , 1998 .

[33]  M. Caron,et al.  Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Uhl,et al.  μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy* , 1997, The Journal of Biological Chemistry.

[35]  M. Gschwendt,et al.  Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes , 1996 .

[36]  Christopher J. Evans,et al.  Morphine Activates Opioid Receptors without Causing Their Rapid Internalization* , 1996, The Journal of Biological Chemistry.

[37]  F. F. Weight,et al.  Differential Opiate Receptor Phosphorylation and Desensitization Induced by Agonists and Phorbol Esters (*) , 1996, The Journal of Biological Chemistry.

[38]  A. Duttaroy,et al.  The Effect of Intrinsic Efficacy on Opioid Tolerance , 1995, Anesthesiology.

[39]  J. Benovic,et al.  A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor. , 1994, The Journal of biological chemistry.

[40]  G. Breitwieser,et al.  Protein kinase-independent inhibition of muscarinic K+ channels by staurosporine. , 1994, The American journal of physiology.

[41]  G. Martiny-Baron,et al.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. , 1993, The Journal of biological chemistry.

[42]  R. Zukin,et al.  Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Connor,et al.  Mu-opioid receptor desensitization: is morphine different? , 2004, British journal of pharmacology.

[44]  J. Traynor,et al.  The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. , 2003, Life sciences.

[45]  A. Duttaroy,et al.  In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice. , 2000, Synapse.

[46]  M. von Zastrow,et al.  Morphine-activated opioid receptors elude desensitization by beta-arrestin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Gschwendt,et al.  Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. , 1996, FEBS letters.